Point72 Asset Management, L.P.
Position in BHC — Bausch Health Companies Inc.
CIK 1603466
STAMFORD, CT
Position in BHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,022,597
+$3,731,183 QoQ
Shares Held
2,235,821
+65.6% QoQ
Ownership
0.598%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 220 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Dec 31, 2024CallValue
$443,300
CallShares
55,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names. BHC ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
201,159 | $108,993,980 | |
| 2 | HLN |
Haleon plc
|
9,264,255 | $86,435,499 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
629,806 | $69,870,677 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,250,639 | $51,313,718 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
659,493 | $42,174,577 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,059,778 | $35,905,278 | |
| 7 | BHC |
Bausch Health Companies Inc.
This page
|
2,235,821 | $11,022,597 | |
| 8 | EOLS |
Evolus, Inc.
|
1,508,518 | $10,469,114 |
All Filings in BHC
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,022,597 | 2,235,821 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $7,291,414 | 1,350,262 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,450,193 | 1,359,740 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,741,500 | 270,000 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $541,500 | 83,694 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $443,300 | 55,000 | Call | Defined | 2025-02-14 | |
| 2024-03-31 | $340,581 | 32,100 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $299,146 | 37,300 | Shares | Defined | 2024-02-14 | |
| 2022-06-30 | $16,567,848 | 1,981,800 | Shares | Defined | 2022-08-15 | |
| 2021-06-30 | $14,407,848 | 491,400 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $72,153,120 | 3,468,900 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $59,506,653 | 3,829,257 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $25,658,400 | 1,402,865 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,525,000 | 550,000 | Call | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||